These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25661473)

  • 21. The 20th century re-emergence of epidemic infectious diseases: lessons learned and future prospects.
    Gubler DJ
    Med J Aust; 2012 Mar; 196(5):293-4. PubMed ID: 22432653
    [No Abstract]   [Full Text] [Related]  

  • 22. Quality vaccines for all people: Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers' Network, 05-07th October 2015, Bangkok, Thailand.
    Pagliusi S; Ting CC; Khomvilai S;
    Vaccine; 2016 Jun; 34(31):3562-7. PubMed ID: 26947496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global tuberculosis control: lessons learnt and future prospects.
    Lienhardt C; Glaziou P; Uplekar M; Lönnroth K; Getahun H; Raviglione M
    Nat Rev Microbiol; 2012 May; 10(6):407-16. PubMed ID: 22580364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modernizing stockpiles of medical countermeasures against smallpox: Benefits, risks, and knowledge gaps.
    Oleksiewicz MB; Steenhard NR; Hansen JE
    Am J Disaster Med; 2015; 10(2):109-20. PubMed ID: 26312493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A strategic vaccine facility for the UK.
    Duggan JM; Brooks TJ
    Vaccine; 2005 Mar; 23(17-18):2090-4. PubMed ID: 15755577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strengthening the supply of routinely recommended vaccines in the United States: a perspective from the American Medical Association.
    Tan L;
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S121-4. PubMed ID: 16447133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Ebola Vaccine Team B: a model for promoting the rapid development of medical countermeasures for emerging infectious disease threats.
    Osterholm M; Moore K; Ostrowsky J; Kimball-Baker K; Farrar J;
    Lancet Infect Dis; 2016 Jan; 16(1):e1-e9. PubMed ID: 26526664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases.
    Le T; Sun C; Chang J; Zhang G; Yin X
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modernizing smallpox vaccine stockpiles.
    Heegaard E
    Am J Disaster Med; 2015; 10(4):354-63. PubMed ID: 27149317
    [No Abstract]   [Full Text] [Related]  

  • 30. Best Practices for Healthcare Facility and Regional Stockpile Maintenance and Sustainment: A Literature Review.
    Rebmann T; McPhee K; Osborne L; Gillen DP; Haas GA
    Health Secur; 2017; 15(4):409-417. PubMed ID: 28767309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccines, inspiring innovation in health.
    Pagliusi S; Dennehy M; Kim H;
    Vaccine; 2018 Nov; 36(48):7430-7437. PubMed ID: 29789241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccines: Shaping global health.
    Pagliusi S; Ting CC; Lobos F;
    Vaccine; 2017 Mar; 35(12):1579-1585. PubMed ID: 28237501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparedness activities and research needs in addressing emerging infectious animal and zoonotic diseases.
    Cardoen S; De Clercq K; Vanholme L; De Winter P; Thiry E; Van Huffel X
    Rev Sci Tech; 2017 Aug; 36(2):557-568. PubMed ID: 30152463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparing for Emerging Infectious Diseases in the Perinatal Population.
    O'Rourke K; Murphy T; Srinivas SK; Pegues DA
    J Obstet Gynecol Neonatal Nurs; 2018 Mar; 47(2):245-253. PubMed ID: 28736265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine shortages: history, impact, and prospects for the future.
    Hinman AR; Orenstein WA; Santoli JM; Rodewald LE; Cochi SL
    Annu Rev Public Health; 2006; 27():235-59. PubMed ID: 16533116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 2014 Ebola outbreak: ethical use of unregistered interventions.
    Krech R; Kieny MP
    Bull World Health Organ; 2014 Sep; 92(9):622. PubMed ID: 25378748
    [No Abstract]   [Full Text] [Related]  

  • 37. Potential impact of antiviral drug use during influenza pandemic.
    Gani R; Hughes H; Fleming D; Griffin T; Medlock J; Leach S
    Emerg Infect Dis; 2005 Sep; 11(9):1355-62. PubMed ID: 16229762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pakistan: the nidus for global polio re-emergence?
    Hadi YB; Sohail AM
    J Infect Public Health; 2015; 8(2):214-5. PubMed ID: 25453296
    [No Abstract]   [Full Text] [Related]  

  • 39. Yellow fever in Africa: public health impact and prospects for control in the 21st century.
    Tomori O
    Biomedica; 2002 Jun; 22(2):178-210. PubMed ID: 12152484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Global lmmunological Observatory to meet a time of pandemics.
    Mina MJ; Metcalf CJE; McDermott AB; Douek DC; Farrar J; Grenfell BT
    Elife; 2020 Jun; 9():. PubMed ID: 32510329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.